Investor Portal

Neuromod Supports Tinnitus Week 2020

Neuromod Supports Tinnitus Week 2020

At Neuromod we specialise in the design and development of multimodal non-invasive neuromodulation technologies for chronic neurological conditions. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic conditions such as tinnitus.

Part of our commitment to delivering solutions to underserved patient populations, involves increasing the awareness and focus on chronic conditions like tinnitus. We know we cannot do this alone, we believe sponsoring the work of associations like the British Tinnitus Association is vital to achieving this common goal.

After supporting the very successful BTA/ATA Transatlantic Joint Networking Dinner at ARO (visit their website news area here, for more information) we were delighted to be asked to support the BTA’s efforts during #TinnitusWeek 2020.

During Tinnitus Week the BTA are advocating for change at Government level, developing 3 clear calls for action. These calls for action were the result of their Tinnitus Roundtable Event which took place in January at the House of Commons, Westminster. We were grateful to be asked to join the discussion.

For more information on the BTA and their efforts during Tinnitus Week 2020 visit their TinnitusWeek Website.

Stay in the Loop

Register for the Neuromod Newsletter to stay up to date on hearing and tinnitus industry news, emerging tinnitus research, and all things Neuromod and Lenire.

Subscribe